We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Strengthening Exercise and Quadriceps Force During Walking

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01538407
Recruitment Status : Completed
First Posted : February 24, 2012
Last Update Posted : January 22, 2014
Sponsor:
Collaborator:
Information provided by (Responsible Party):

February 20, 2012
February 24, 2012
January 22, 2014
March 2012
October 2013   (Final data collection date for primary outcome measure)
Change from baseline in peak quadriceps force during walking at 12 weeks [ Time Frame: Baseline and at 12 weeks ]
Estimates of the quadriceps muscle forces during locomotion are calculated using a biomechanical model based on data from gait analysis
Same as current
Complete list of historical versions of study NCT01538407 on ClinicalTrials.gov Archive Site
  • Change from baseline in quadriceps power and work during walking at 12 weeks [ Time Frame: Baseline and after 12 weeks ]
    Estimated from gait analysis
  • Change from baseline in knee compressive force during walking at 12 weeks [ Time Frame: Baseline and after 12 weeks ]
    Estimated from biomechanical modelling of data from gait analysis
Same as current
Not Provided
Not Provided
 
Strengthening Exercise and Quadriceps Force During Walking
A Study of Strengthening Exercise on Quadriceps Force During Walking

This is a longitudinal, randomized, controlled interventional multi centric study on the effects of lower leg strengthening exercise on quadriceps force during walking in people with knee osteoarthritis. At each study centre twenty subjects will be included, for a total of 40 participants. Subjects will be randomized equally (1:1) into 1 active arm and 1 control arm.

The objective of the study is to evaluate the effect of twelve weeks of quadriceps strengthening on the mechanical output of the quadriceps during locomotion. A secondary purpose is to explore the relationship between quadriceps strengthening and compressive knee loadings. The hypothesis is that quadriceps strength training will not change quadriceps force, power, and work in locomotion in people with knee osteoarthritis.

Primary outcome is quadriceps force during walking, secondary outputs are quadriceps power and work and knee compressive loads during walking. Explorative measures are isometric and concentric isokinetic leg muscle strength, radiographic score of the knee (Kellgren and Lawrence), a one-leg rise from chair test (maximum number of reps) and a lateral step-up test (maximum number of reps).

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Basic Science
Knee Osteoarthritis
Other: Strength Training
The exercises will be performed in standard strength training equipment. Prior to each of the strengthening exercise sessions, a warm up phase is performed by 5-10 minutes of ergometer cycling at a moderate intensity. Muscle strengthening exercises will be performed according to the standard progressive resistance and overload principle. The exercise programme consists of three exercises performed with three sets of 10 repetitions at 60%-85% of patient's 10RM. Training load will be progressed by means of bi-weekly estimates of muscle strength to ensure a constant load of 60%-85% RM. Exercises are: 1. Leg extension, 2. Leg press, and 3. Forward lunges.
  • No Intervention: Control group
    No intervention group
  • Active Comparator: Strength training group
    The knee extension strength training intervention period is 12 weeks with training sessions three times per week.
    Intervention: Other: Strength Training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
October 2013
October 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

A medical doctor will perform the screening of potential participants. Subjects must meet the following inclusion criteria to be eligible for study entry:

  • Knee OA diagnosed according to the American College of Rheumatology criteria (26), with clinical symptoms and radiographically verified tibio-femoral osteoarthritis in one or both knees.
  • Aged between 40 and 65 yrs.
  • Untrained (i.e. less than 2 hours of exercise per week)
  • Subject must not be using assistive walking device
  • Willing and able to complete study visits and procedures
  • Willing to hold activity and exercise level generally consistent during the study except that encompassed in the study.
  • In general good health, in the opinion of the investigator, based on medical history and physical examination and, if necessary, laboratory values. Laboratory tests are prescribed by the medical doctor at the screening visit.
  • A body mass index (BMI) of 19<BMI≤32kg/m2
  • Speaks, reads and writes Danish and/or English language

Exclusion Criteria:

Subjects who meet any of the following exclusion criteria will be ineligible for study entry:

  • Subjects depending on walking device
  • Pregnant or breastfeeding
  • Radiographic evidence of Patello-femoral knee OA only (and no tibio-femoral OA).
  • History of symptoms of autoimmune disorders (e.g., inflammatory bowel disease, multiple sclerosis, lupus, rheumatoid arthritis)
  • Planned surgical procedure during the duration of the study
  • History or diagnosis of musculoskeletal injuries or pathologies, including but not limited to:

    • Anterior cruciate ligament injuries
    • Meniscal injuries related to trauma (degenerative changes allowed)
    • Patellofemoral Pain Syndrome
    • Low back pain
  • History, diagnosis, or signs and symptoms of clinically significant cardiovascular disease, including but not limited to:

    • Ischemic heart disease
    • Arthrosclerosis
    • Peripheral artery disease
  • History, diagnosis, or signs and symptoms of diabetes
  • History, diagnosis, or signs and symptoms of neurological disorders including but not limited to

    • Stroke
    • Parkinson's disease
    • Multiple sclerosis
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Denmark,   United States
 
 
NCT01538407
117.0
No
Not Provided
Not Provided
Marius Henriksen, Frederiksberg University Hospital
Frederiksberg University Hospital
East Carolina University
Principal Investigator: Paul Devita, MSc, PhD The College of Health and Human Performance, Department of Exercise and Sport Science, Minges Coliseum Greenville, U.S.A.
Study Director: Marius Henriksen, PhD The Parker Institute, Frederiksberg University Hospital
Frederiksberg University Hospital
January 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP